Insmed

NASDAQ: INSM · Real-Time Price · USD
127.79
4.92 (4.00%)
At close: Aug 14, 2025, 3:59 PM
128.75
0.75%
Pre-market: Aug 15, 2025, 07:05 AM EDT

Insmed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
363.71M 305.21M 245.36M 188.46M
Cost of Revenue
85.74M 65.57M 55.13M 44.15M
Gross Profit
277.96M 239.63M 190.23M 144.31M
Operating Income
-878.25M -709.63M -478.12M -367.76M
Interest Income
n/a n/a 11.08M 174K
Pretax Income
-910.07M -747.01M -480.15M -436.41M
Net Income
-913.77M -749.57M -481.53M -434.65M
Selling & General & Admin
461.12M 344.5M 265.78M 234.27M
Research & Development
598.37M 571.01M 397.52M 272.74M
Other Expenses
96.73M 33.75M 5.05M 5.05M
Operating Expenses
1.16B 949.26M 668.36M 512.07M
Interest Expense
84.91M 81.69M 26.45M 40.47M
Selling & Marketing Expenses
n/a n/a 20.8M n/a
Cost & Expenses
1.24B 1.01B 723.48M 556.22M
Income Tax Expense
3.71M 2.56M 1.38M -1.76M
Shares Outstanding (Basic)
164.04M 140.43M 123.03M 112.11M
Shares Outstanding (Diluted)
164.04M 140.43M 123.03M 112.11M
EPS (Basic)
-5.57 -5.34 -3.91 -3.88
EPS (Diluted)
-5.57 -5.34 -3.91 -3.88
EBITDA
-814.14M -660.18M -429.44M -375.09M
EBIT
-829.81M -670.76M -457.7M -397.83M
Depreciation & Amortization
11.01M 10.58M 24.27M 27.85M